As expected, after reducing eIF3a expression, these three proteins levels were significantly decreased (Fig. 2E, F), suggesting eIF3a might promote the growth of DLBCL cells via regulating cell proliferation and cell cycle. The gene discussed is EIF3A; the disease is diffuse large B-cell lymphoma.